Currently, some clinical indicators and tumor staging systems have been reported that can predict the prognosis of patients, such as the Barcelona Clinical Liver Cancer Staging (BCLC), serum alpha-fetoprotein (AFP), tumor size, portal vein tumor thrombus (PVTT), and the peripheral blood neutrophil-to-lymphocyte ratio15–23. Here, AFP is linked to liver cancer.